Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-ketamine intraoperative sedation for postoperative depression in elderly surgical patients
ACTRN12610001090000Phase 2Completed
- Sponsor
- Margarida Castanheira Rodrigues Bretas Bastos, MD
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of esketamine and midazolam in major depressive disorder (MDD) (4 arms), sponsored by Margarida Castanheira Rodrigues Bretas Bastos, MD. Primary endpoint: Improvement in depression. Started May 2006; status: completed.
02
Drugs
esketaminemidazolam
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ACTRN12610001090000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610001090000.